TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A two-year clinical trial involving 365 older adults at elevated risk of Alzheimer’s found no measurable improvement in memory or other cognitive abilities from daily fish oil supplements compared with placebo. DHA levels in participants’ cerebrospinal fluid rose, but brain imaging also showed no prevention of hippocampal shrinkage.
A two-year clinical trial found that daily fish oil supplements did not measurably improve memory or other thinking abilities, or prevent shrinkage of a memory-related brain region, among 365 adults ages 55 to 80 at elevated risk of Alzheimer’s disease. Researchers at Keck Medicine of USC reported that the supplement raised DHA levels in participants’ cerebrospinal fluid, but those higher levels did not translate into a detectable benefit compared with placebo.
The participants were randomly assigned to take either a daily supplement providing 2,000 milligrams of DHA, an omega-3 fatty acid, or an inactive placebo. The study was double-blind, meaning neither participants nor researchers knew who was receiving the active supplement during the trial. Participants were selected in part because they rarely ate fish, a major dietary source of omega-3s, and were considered at increased risk for Alzheimer’s.
To check whether DHA reached the central nervous system, researchers measured its concentration in cerebrospinal fluid, which surrounds the brain and spinal cord. After six months, levels had risen by an average of 17% among those taking the supplement. At two years, however, cognitive testing showed no significant advantage over placebo. Brain imaging also found no evidence that the supplements prevented shrinkage of the hippocampus, a region involved in forming and organizing memories.
Nearly 47% of participants carried APOE4, a genetic variant associated with increased Alzheimer’s risk. Carrying APOE4 does not mean a person will develop the disease. The study’s findings apply to the enrolled group and to the tested supplement regimen; they do not establish that every fish oil product, dose, or population would have the same results.
What the Trial Says About Prevention
The findings matter because fish oil is widely used with the expectation that omega-3s may help preserve memory as people age. The original ScienceDaily report says Americans spend more than $1 billion each year on supplements containing omega-3 fatty acids. This trial offers a direct test of one common prevention claim: in older adults at elevated Alzheimer’s risk who rarely ate fish, taking high-dose DHA for two years did not produce measurable cognitive or hippocampal benefits.
The result is not evidence that omega-3s have no role in brain biology. DHA is a component of brain-cell membranes, and the trial showed that supplementation increased its measured level in cerebrospinal fluid. Rather, the study found that raising DHA levels was not enough to improve the measured outcomes in this group over this period. It also does not determine whether fish oil helps people with different diets, health profiles, or stages of disease, or whether longer follow-up would show a different result.
For readers, the distinction is important: a nutrient’s biological role does not by itself prove that taking it as a supplement prevents disease. The researchers’ results do not support using fish oil as an established Alzheimer’s-prevention measure. People considering supplements for personal health reasons should discuss them with a qualified health professional.
DHA omega-3 fish oil supplements 2000 mg
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Who Took Part in the Trial
The study enrolled 365 adults between 55 and 80 who rarely ate fish and were considered at elevated risk of Alzheimer’s disease. Researchers compared a daily DHA supplement with placebo and assessed cognition at the start and after two years. The double-blind design was intended to reduce bias in how participants and researchers interpreted the results.
The trial focused on DHA because it is a major component of brain-cell membranes and supports normal nerve-cell function. Researchers also examined the hippocampus through brain imaging because it is involved in memory and can be affected by aging and Alzheimer’s-related changes. The study, reported in eBioMedicine, tested whether raising DHA availability would correspond with changes in cognition or this imaging measure.
Researchers also noted that omega-3s are obtained through food, including fish, and that dietary patterns supply combinations of nutrients rather than one isolated compound. The report discusses a Mediterranean-style diet as a possible area for further research, not as an intervention proven by this trial to prevent Alzheimer’s.
third-party tested omega-3 DHA supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Questions Beyond This Study
The reported results do not show whether a different dose, a longer period of use, or supplementation in people with different diets or health conditions would have different effects. The trial followed participants for two years and measured cognitive-test performance and hippocampal size; it does not establish the supplements’ effect on every aspect of brain health or on an individual’s future risk of Alzheimer’s.
It is also unclear why the rise in cerebrospinal-fluid DHA did not correspond to improved outcomes. The researchers are investigating how the brain absorbs and uses omega-3s and whether diet, age, genetic risk, and overall health may affect that process. The report describes possible differences between taking omega-3s alone and consuming them within a broader diet, but this trial did not test whether a Mediterranean-style diet prevents Alzheimer’s.
The provided report does not give detailed results for separate subgroups, such as APOE4 carriers versus noncarriers, or enough information to assess all possible adverse effects. No conclusion about individual supplement safety or personal treatment choices should be drawn from the reported cognitive findings alone.
fish oil supplements with DHA and EPA
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Researchers Study Omega-3 Use
Yassine and colleagues say they are continuing research into how the brain processes omega-3 fatty acids and why increased DHA availability did not produce measurable benefits in this trial. Their next questions include whether dietary pattern, general health, age, and genetic factors influence how the brain uses these nutrients.
The study report does not announce a date for further results or describe a specific next trial. Until more evidence is available, the clearest finding remains limited to this study: among older adults at elevated Alzheimer’s risk who rarely ate fish, two years of daily DHA supplementation raised measured cerebrospinal-fluid DHA but did not improve cognition or prevent hippocampal shrinkage compared with placebo.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the two-year fish oil study find?
Among 365 adults ages 55 to 80 at elevated Alzheimer’s risk, daily DHA supplements did not lead to significantly better cognitive test results than placebo. Imaging also found no prevention of hippocampal shrinkage.
Did the supplement reach participants’ brains?
Researchers measured DHA in cerebrospinal fluid. After six months, levels were an average of 17% higher in the supplement group, according to the report. That increase did not produce a measurable cognitive or hippocampal benefit over the two-year trial.
Does the study show that omega-3s have no role in brain health?
No. The study tested a particular DHA supplement regimen in a specific group. Its finding was that raising DHA levels this way did not measurably improve the outcomes assessed; it does not rule out every possible role for omega-3s or dietary sources.
Did the trial prove a Mediterranean-style diet prevents Alzheimer’s?
No. The report says researchers are investigating whether omega-3s may work differently as part of a broader dietary pattern. The trial described here tested supplements against placebo, not a Mediterranean-style diet as an Alzheimer’s-prevention treatment.
Should people stop taking fish oil?
The study does not give personal medical advice or establish what an individual should do. Anyone considering whether to start, stop, or change a supplement should discuss that decision with a qualified health professional.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
